Skip to content
No picture yet

Procytox 50 mg – DIN 02241796

Procytox is Cyclophosphamide 50 mg (tablet), sold in Canada. It is used for multiple sclerosis, myasthenia gravis and breast cancer. It is supplied by Baxter Corporation. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Cyclophosphamide 50 mg

Brand
Procytox
Strength
50 mg
Used for
Multiple sclerosis, myasthenia gravis and breast cancer
Form
Tablet
Manufacturer
Baxter Corporation
Drug class
Cancer or immune medicine
Sold in
Canada
DIN
02241796

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cyclophosphamide pills and guides

What is Cyclophosphamide used for?

Cyclophosphamide is used for multiple sclerosis, myasthenia gravis, breast cancer and multiple myeloma.

Medicine type
Cancer or immune medicine
Official uses from the US prescribing label

Malignant Diseases

Cyclophosphamide capsules are indicated for the treatment of: • malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin’s disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma • multiple myeloma • leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia (cyclophosphamide given during remission is effective in prolonging its duration) • mycosis fungoides (advanced disease) • neuroblastoma (disseminated disease) • adenocarcinoma of the ovary • retinoblastoma • carcinoma of the breast

Cyclophosphamide capsules, although effective alone in susceptible malignancies, is more frequently used concurrently or sequentially with other antineoplastic drugs.

Minimal Change Nephrotic Syndrome in Pediatric Patients

Cyclophosphamide capsules are indicated for the treatment of biopsy proven minimal change nephrotic syndrome in pediatric patients who failed to adequately respond to or are unable to tolerate adrenocorticosteroid therapy.

Limitations of Use:

The safety and effectiveness of cyclophosphamide capsules for the treatment of nephrotic syndrome in adults or other renal disease has not been established.

From the FDA-approved label on DailyMed (published Sep 29, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02241796.
  • It names Procytox, Cyclophosphamide 50 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Procytox by Baxter Corporation.

In Canada: prescription only.

Ingredients

Active: Cyclophosphamide

Other Cyclophosphamide pills